GlaxoSmithKline Pharmaceuticals Ltd. (GLAXO)
Market Closed
15 Jun, 10:00
XNSE XNSE Primary MSE ₹
2,115. 00
-6
-0.2829%
₹
416.26B Market Cap
60.37 P/E Ratio
48% Div Yield
160,924 Volume
40.12 Eps
₹ 2,121
Previous Close Want to track GLAXO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GlaxoSmithKline Pharmaceuticals Ltd. (GLAXO) Statistics
Valuation metrics
Market Cap 416.26B
Enterprise value 348.71B
Trailing P/E (ttm) 34.7
Forward P/E -
PEG ratio 2.97
Price/Sales (ttm) 9.4
Price/Book (mrq) 15.85
Enterprise Value/Revenue 9.12
Enterprise Value/EBITDA 24.23
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 118.17K
Average volume (90 days) 81.45K
Price summary
52-Week low 2,090
52-Week high 3,500
Beta -
50-Day moving average 2,318.39
200-Day moving average 2,427.01
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 57
Trailing annual dividend yield 0.0269%
5-Year annual dividend yield -
Payout ratio 0.69
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 11 Sep 2018
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.27%
Operating margin 0.33%
Operational effectiveness
Return on assets 0.24%
Return on equity 0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 225.56
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 61.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 162.69
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 2.03%
Book value per share (mrq) 133.83
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
